PATENT CLAIM ANALYSIS

Application Number: 15967489
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "139100"]

Abstract:
The invention relates to diagnosis, prognosis and treatment of neurological diseases. In one embodiment, the present invention provides methods and kits that diagnose whether a subject has a neurological disease or susceptibility to a neurological disease by evaluating nuclear stress body (NSB) levels. Further described are methods and kits that prognose a neurological disease in a subject by monitoring changes in NSB levels. Also described are methods and kits that treat neurological diseases by administering one or more inhibitors of NSB signaling to a patient, as well as compositions containing one or more NSB signaling inhibitors. Medical conditions suitable with various embodiments of the invention include but are not limited to ALS, FTLD, dementia and AD.

Claim (Index 16):
The method of  claim 13 , the subject received, is receiving, or will receive a neurodegenerative disease treatment.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 91.0
- Lexical Diversity: 1.80282
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15028680', '15962691', '14019380', '15828842', '14935024']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6634736556233558
- 35 USC 102 Novelty (BERT): 0.5737503960896732
- Combined Prediction Score: 0.6545013296699875
- Mean Citation Score: 235.86974
- Max Citation Score: 494.29846
- Similarity Product: 325.98264693807363

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test